Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
By deploying molecular simulations, our approach comprehensively covers a broad array of proteins, tracking their flexibility and dynamics individually and within complexes. Ensemble virtual screening is utilised to take into account conformational dynamics, identifying pivotal binding sites located within functional regions and at allosteric locations. This thorough exploration ensures that every conceivable mechanism of action is considered, aiming to identify new therapeutic targets and advance lead compounds throughout a vast spectrum of biological functions.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q9P2E2
UPID:
KIF17_HUMAN
Alternative names:
KIF3-related motor protein
Alternative UPACC:
Q9P2E2; A2A3Q7; A2A3Q8; O95077; Q53YS6; Q5VWA9; Q6GSA8; Q8N411
Background:
Kinesin-like protein KIF17, also known as a KIF3-related motor protein, plays a pivotal role in neuronal function. It is a dendrite-specific motor protein that, in association with the Apba1-containing complex, transports vesicles with NMDA receptor subunit NR2B along microtubules. This process is crucial for synaptic plasticity and memory formation.
Therapeutic significance:
Understanding the role of Kinesin-like protein KIF17 could open doors to potential therapeutic strategies. Its involvement in the transport of critical components for synaptic function highlights its potential as a target in neurological disorders.